{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:29:12Z","timestamp":1787624952794,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bcmd.2012.11.009","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T22:39:36Z","timestamp":1356129576000},"page":"190-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Huichun","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison R.","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi V.","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2012.11.009_bb0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0010","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0015","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0025","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1182\/blood.V51.2.189.189","article-title":"Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis","volume":"51","author":"Jacobson","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0045","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","article-title":"Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice","volume":"111","author":"Tiedt","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0050","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1182\/blood-2007-05-091579","article-title":"Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice","volume":"111","author":"Xing","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0055","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0060","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2010.10.013","article-title":"Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling","volume":"18","author":"Chen","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0070","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nm1008-1036","article-title":"The evolution of our thinking about microRNAs","volume":"14","author":"Ambros","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1261\/rna.2183803","article-title":"A uniform system for microRNA annotation","volume":"9","author":"Ambros","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrm1644","article-title":"MicroRNA biogenesis: coordinated cropping and dicing","volume":"6","author":"Kim","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0085","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1073\/pnas.0913574107","article-title":"MicroRNA miR-125a controls hematopoietic stem cell number","volume":"107","author":"Guo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0090","doi-asserted-by":"crossref","first-page":"21505","DOI":"10.1073\/pnas.1016218107","article-title":"MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets","volume":"107","author":"Ooi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0095","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1073\/pnas.1009798107","article-title":"MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output","volume":"107","author":"O'Connell","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.devcel.2008.03.012","article-title":"MicroRNA-mediated control of cell fate in megakaryocyte\u2013erythrocyte progenitors","volume":"14","author":"Lu","year":"2008","journal-title":"Dev. Cell"},{"issue":"17","key":"10.1016\/j.bcmd.2012.11.009_bb0105","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2010-12-324715","article-title":"Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome","volume":"118","author":"Kumar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0110","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.leukres.2009.04.039","article-title":"MicroRNAs in normal and malignant myelopoiesis","volume":"33","author":"Pelosi","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0115","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1182\/blood-2011-01-292011","article-title":"MicroRNAs in platelet production and activation","volume":"117","author":"Edelstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0120","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-03-291971","article-title":"MicroRNA function in myeloid biology","volume":"118","author":"O'Connell","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.22729","article-title":"MicroRNAs: allies or foes in erythropoiesis?","volume":"227","author":"Byon","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0130","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.exphem.2007.08.021","article-title":"Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis","volume":"35","author":"Bruchova","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0135","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3324\/haematol.12706","article-title":"Aberrant expression of microRNA in polycythemia vera","volume":"93","author":"Bruchova","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0140","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.exphem.2007.08.020","article-title":"MicroRNA expression profile in granulocytes from primary myelofibrosis patients","volume":"35","author":"Guglielmelli","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0145","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1182\/blood-2010-09-306506","article-title":"Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera","volume":"117","author":"Guglielmelli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0150","article-title":"miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation","author":"Lin","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0155","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.exphem.2008.05.006","article-title":"Phenotypic variability within the JAK2 V617F-positive MPD: roles of progenitor cell and neutrophil allele burdens","volume":"36","author":"Moliterno","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0160","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3324\/haematol.2009.014407","article-title":"Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders","volume":"95","author":"Stein","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0165","doi-asserted-by":"crossref","first-page":"874146","DOI":"10.1155\/2011\/874146","article-title":"Gender and vascular complications in the JAK2 V617F-positive myeloproliferative neoplasms","volume":"2011","author":"Stein","year":"2011","journal-title":"Thromb."},{"issue":"6","key":"10.1016\/j.bcmd.2012.11.009_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11739-011-0634-3","article-title":"Polycythemia vera: gender-related phenotypic differences","volume":"7","author":"Landolfi","year":"2012","journal-title":"Intern Emerg Med."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0175","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0180","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/blood-2010-12-324715","article-title":"Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome","volume":"118","author":"Kumar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0185","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2008-09-178863","article-title":"A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis","volume":"114","author":"Klimchenko","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0190","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1073\/pnas.0712312105","article-title":"A GATA-1-regulated microRNA locus essential for erythropoiesis","volume":"105","author":"Dore","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0195","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2008-05-155812","article-title":"miR-451 regulates zebrafish erythroid maturation in vivo via its target gata2","volume":"113","author":"Pase","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0200","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.exphem.2007.03.014","article-title":"MicroRNA expression dynamics during murine and human erythroid differentiation","volume":"35","author":"Zhan","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0205","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0215","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1101\/gr.111385.110","article-title":"MicroRNA programs in normal and aberrant stem and progenitor cells","volume":"21","author":"Arnold","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0220","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood-2006-04-018259","article-title":"Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia","volume":"108","author":"Scott","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0230","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0235","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1182\/blood-2011-12-395087","article-title":"Spliceosomal gene aberrations are rare, coexist with oncogenic mutations, and are unlikely to exert a driver effect in childhood MDS and JMML","volume":"119","author":"Hirabayashi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0240","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","article-title":"Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis","volume":"119","author":"Makishima","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0245","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood-2011-11-390252","article-title":"Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms reveals recurrent SRSF2 mutations which are associated with adverse outcome","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0250","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3109\/10428191003629362","article-title":"miR-451 enhances erythroid differentiation in K562 cells","volume":"51","author":"Bruchova-Votavova","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2012.11.009_bb0255","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2012.11.009_bb0260","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-10-1092","article-title":"Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F","volume":"16","author":"Berkofsky-Fessler","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612002288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979612002288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:07Z","timestamp":1761049747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979612002288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1079979612002288"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.009","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA deregulation in polycythemia vera and essential thrombocythemia patients","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2012.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}